Papadaki C - Search Results

1

MicroRNAs Regulating Tumor and Immune Cell Interactions in the Prediction of Relapse in Early Stage Breast Cancer.

Papadaki C, Thomopoulou K, Monastirioti A, Koronakis G, Papadaki MA, Rounis K, Vamvakas L, Nikolaou C, Mavroudis D, Agelaki S. Papadaki C, et al. Among authors: papadaki ma. Biomedicines. 2021 Apr 13;9(4):421. doi: 10.3390/biomedicines9040421. Biomedicines. 2021. PMID: 33924670 Free PMC article.

2

Correlation of BRCA1, TXR1 and TSP1 mRNA expression with treatment outcome to docetaxel-based first-line chemotherapy in patients with advanced/metastatic non-small-cell lung cancer.

Papadaki C, Tsaroucha E, Kaklamanis L, Lagoudaki E, Trypaki M, Tryfonidis K, Mavroudis D, Stathopoulos E, Georgoulias V, Souglakos J. Papadaki C, et al. Br J Cancer. 2011 Jan 18;104(2):316-23. doi: 10.1038/sj.bjc.6606027. Epub 2010 Dec 14. Br J Cancer. 2011. PMID: 21157449 Free PMC article.

3

PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer.

Papadaki C, Sfakianaki M, Lagoudaki E, Giagkas G, Ioannidis G, Trypaki M, Tsakalaki E, Voutsina A, Koutsopoulos A, Mavroudis D, Georgoulias V, Souglakos J. Papadaki C, et al. Br J Cancer. 2014 Oct 28;111(9):1757-64. doi: 10.1038/bjc.2014.492. Epub 2014 Sep 18. Br J Cancer. 2014. PMID: 25233397 Free PMC article.

4

ERCC1 SNPs as Potential Predictive Biomarkers in Non-Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy.

Kalikaki A, Voutsina A, Koutsopoulos A, Papadaki C, Sfakianaki M, Yachnakis E, Xyrafas A, Kotsakis A, Agelaki S, Souglakos J, Mavroudis D, Georgoulias V. Kalikaki A, et al. Among authors: papadaki c. Cancer Invest. 2015 Apr;33(4):107-13. doi: 10.3109/07357907.2014.1001897. Epub 2015 Feb 3. Cancer Invest. 2015. PMID: 25647444

5

Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer.

Papadaki C, Stratigos M, Markakis G, Spiliotaki M, Mastrostamatis G, Nikolaou C, Mavroudis D, Agelaki S. Papadaki C, et al. Breast Cancer Res. 2018 Jul 11;20(1):72. doi: 10.1186/s13058-018-1001-3. Breast Cancer Res. 2018. PMID: 29996899 Free PMC article.

6

Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer.

Papadaki C, Stoupis G, Tsalikis L, Monastirioti A, Papadaki M, Maliotis N, Stratigos M, Mastrostamatis G, Mavroudis D, Agelaki S. Papadaki C, et al. Among authors: papadaki m. Oncotarget. 2019 Jan 29;10(9):966-981. doi: 10.18632/oncotarget.26629. eCollection 2019 Jan 29. Oncotarget. 2019. PMID: 30847025 Free PMC article.

7

Messenger-RNA Expression of Five Gemcitabine Sensitivity-related Genes Predicting Outcome in Advanced-stage Non-small Cell Lung Cancer.

Ioannidis G, Papadaki C, Lagoudaki E, Tzardi M, Trypaki M, Stathopoulos E, Mavroudis D, Georgoulias V, Souglakos J. Ioannidis G, et al. Among authors: papadaki c. Anticancer Res. 2020 Feb;40(2):901-913. doi: 10.21873/anticanres.14023. Anticancer Res. 2020. PMID: 32014934

8

Clinical Relevance of Immune Checkpoints on Circulating Tumor Cells in Breast Cancer.

Papadaki MA, Koutsopoulos AV, Tsoulfas PG, Lagoudaki E, Aggouraki D, Monastirioti A, Koutoulaki C, Apostolopoulou CA, Merodoulaki AC, Papadaki C, Mavroudis D, Agelaki S. Papadaki MA, et al. Among authors: papadaki c. Cancers (Basel). 2020 Feb 6;12(2):376. doi: 10.3390/cancers12020376. Cancers (Basel). 2020. PMID: 32041353 Free PMC article.

9

Correlation of PKM2 and CD44 Protein Expression with Poor Prognosis in Platinum-Treated Epithelial Ovarian Cancer: A Retrospective Study.

Papadaki C, Manolakou S, Lagoudaki E, Pontikakis S, Ierodiakonou D, Vogiatzoglou K, Messaritakis I, Trypaki M, Giannikaki L, Sfakianaki M, Kalykaki A, Mavroudis D, Tzardi M, Souglakos J. Papadaki C, et al. Cancers (Basel). 2020 Apr 20;12(4):1013. doi: 10.3390/cancers12041013. Cancers (Basel). 2020. PMID: 32326107 Free PMC article.

10

Circulating MicroRNAs Regulating DNA Damage Response and Responsiveness to Cisplatin in the Prognosis of Patients with Non-Small Cell Lung Cancer Treated with First-Line Platinum Chemotherapy.

Papadaki C, Monastirioti A, Rounis K, Makrakis D, Kalbakis K, Nikolaou C, Mavroudis D, Agelaki S. Papadaki C, et al. Cancers (Basel). 2020 May 19;12(5):1282. doi: 10.3390/cancers12051282. Cancers (Basel). 2020. PMID: 32438598 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page